Latest / Stock Movers / Ulta Beauty Leaps, Cooper Companies Slump, Regeneron Plunges on Disappointing Data
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The Stock Movers podcast,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:14Speaker 1: harnessing the power of Bloomberg data. Let's take a look
- 0:18Speaker 1: at some of the stocks on the move today.
- 0:19Speaker 2: I'm Paul Sweny along with John Tucker.
- 0:21Speaker 1: They were joined by Bloomers Jess Ben Jess.
- 0:24Speaker 3: What are you looking at today? I wanted to point
- 0:25Speaker 3: out what's going on in retail because I feel like
- 0:28Speaker 3: so many times when we have these companies come out,
- 0:30Speaker 3: it's kind of a tale of two different stories depending
- 0:32Speaker 3: on which retailer we're talking about. So I wanted to
- 0:34Speaker 3: start with Alta, a beauty U. LTA's a taker symbol
- 0:38Speaker 3: on this up about fifteen percent on pace for its
- 0:40Speaker 3: best day since April twenty twenty. There is so quite
- 0:44Speaker 3: the move there, and it's atop the leader board when
- 0:46Speaker 3: you're looking at the S and P five hundred, so
- 0:49Speaker 3: the best performer today, So if you're looking at that,
- 0:51Speaker 3: of course a cosmetics retailer. It actually jumped on a
- 0:54Speaker 3: profit forecast that was boost us. And also annals are
- 0:57Speaker 3: flagging some of that strong execution at the company, with
- 1:00Speaker 3: City analysts also noting that some of the competitive pressures
- 1:04Speaker 3: from its new points of distribution sale Sephora is beginning
- 1:07Speaker 3: to abate there, So looking at that an R function,
- 1:11Speaker 3: I know that Paul Sweety likes to keep an eye
- 1:14Speaker 3: on here when you're looking at those cell side recommendations.
- 1:17Speaker 3: So sixteen buys A thirteen holds two cells so far.
- 1:21Speaker 3: But then also if you move over and you look
- 1:23Speaker 3: at apparel, specifically looking at Gap, which reported earnings after
- 1:28Speaker 3: the bell yesterday, that stucks down over twenty percent this
- 1:30Speaker 3: morning alone, so it's erased its year to date gains.
- 1:34Speaker 3: And it's also its biggest drop as far as word's
- 1:37Speaker 3: at today if it goes through the close since November
- 1:39Speaker 3: of twenty twenty one. There, So if you're looking also, unfortunately,
- 1:42Speaker 3: we've talked so much about tariffs tied to the consumer,
- 1:45Speaker 3: so Gap was warning and it did predict that a
- 1:48Speaker 3: tariff impact of as much as three hundred million dollars
- 1:51Speaker 3: could impact the company this year, and it revealed some
- 1:54Speaker 3: of that stubborn weakness that two of its smaller brands
- 1:56Speaker 3: when it comes to Ni Republic as well as Athletic Club.
- 2:00Speaker 2: Heard of the Lipstick index.
- 2:02Speaker 3: Of course, it's it's a key crucial tide of the economy.
- 2:04Speaker 3: It was a little tricky though during COVID during the pandemic,
- 2:07Speaker 3: because everyone was tied stuck at home, so it wasn't well.
- 2:12Speaker 2: The CEO. I love this, the CEO. Many consumers indicate
- 2:15Speaker 2: they're leaning into beauty as a comfort and a scate.
- 2:17Speaker 3: It's also one of those things that people view as
- 2:20Speaker 3: recession proof because no matter and then also that's something
- 2:23Speaker 3: when I've talked to portfolio managers about with say Estay
- 2:26Speaker 3: Later and different companies like that. Even though they've had
- 2:28Speaker 3: some issues with their exposures overseas taking some hits there,
- 2:32Speaker 3: a lot of times they own those stocks because they
- 2:34Speaker 3: view them as regardless of what the cycles are in
- 2:36Speaker 3: the economy. Women and others that are, you know, buying
- 2:39Speaker 3: some of these beauty products, they're going to continue to
- 2:41Speaker 3: do so.
- 2:41Speaker 2: So when you see macro uncertainty, do you say to yourself,
- 2:44Speaker 2: I'm going to go get some eyeliner.
- 2:48Speaker 3: The fair. I mean, I'm still you know, purchasing.
- 2:54Speaker 2: Companies.
- 2:55Speaker 1: What's going on with Ball's.
- 2:56Speaker 3: Over and he wants to move on to Cooper companies.
- 2:58Speaker 3: So this is a medical device company. It's headquartered in California,
- 3:02Speaker 3: So if you look at this, it's actually one of
- 3:04Speaker 3: the worst performers in the S and P five hundred
- 3:07Speaker 3: if you're looking at that today two So it has
- 3:10Speaker 3: a market cap over ten billion dollars, but it's down
- 3:13Speaker 3: twelve percent. COO is the ticker symbol for Cooper Company,
- 3:15Speaker 3: so it's on pace for its worst drop since March
- 3:18Speaker 3: of twenty twenty. Obviously that was the height of the
- 3:20Speaker 3: when the pandemic started there. So actually what happened here
- 3:24Speaker 3: it cut its organic growth outlook, So that's the problem
- 3:29Speaker 3: that's really weighing on the stock right now too. And
- 3:31Speaker 3: of course it's also a contact lens maker, and that's
- 3:34Speaker 3: why people are watching it pretty closely. So that, yeah, exactly,
- 3:38Speaker 3: So that's why you've heard that name if it does
- 3:40Speaker 3: sound familiar. So it reported better than expected results for
- 3:42Speaker 3: the second quarter, but that disappointing guidance ended up spurring
- 3:45Speaker 3: a downgrade by JP Morgan right now, so they actually
- 3:49Speaker 3: cut their target to neutral from overweight. The price target
- 3:52Speaker 3: is seventy six dollars previously was one hundred and ten dollars.
- 3:55Speaker 1: Generon pharmaceutical.
- 3:57Speaker 3: Yeah, so this one is also actually the worst perform
- 4:00Speaker 3: former in the S and P five hundred this morning too,
- 4:03Speaker 3: So r EGN is the ticker symbol for Regeneral On Pharmaceuticals,
- 4:07Speaker 3: down seventeen percent at this point this morning, on pace
- 4:10Speaker 3: for its worst day since April of twenty eleven there,
- 4:14Speaker 3: So that's quite the drop when you're looking at that.
- 4:16Speaker 3: And also this happens to happen when it actually had
- 4:19Speaker 3: an even smoker's lung drug data trial here, and that's
- 4:22Speaker 3: why you're seeing that as well as if you're moving
- 4:24Speaker 3: over and just looking at the not even just healthcare
- 4:28Speaker 3: index in the S and P five hundred, but also
- 4:30Speaker 3: specifically when it comes to pharmaceutical stocks that's weighing more
- 4:33Speaker 3: broadly all those shares this morning.
- 4:37Speaker 1: The Stock Movers podcast from Bloomberg Radio. Check back with
- 4:41Speaker 1: us throughout the day for the latest roundup of companies
- 4:44Speaker 1: making news on Wall Street and for the latest market
- 4:47Speaker 1: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:51Speaker 1: Bloomberg dot com, and on Applecarplay and Android Auto with
- 4:55Speaker 1: the Bloomberg Business app.